700015007: Eslicarbazepine acetate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Substance with cytochrome P450 inhibitor mechanism of action (substance)\Cytochrome P450 2C19 inhibitor\Eslicarbazepine acetate

\Drug or medicament (substance)\Central nervous system agent (substance)\Anticonvulsant (substance)\Eslicarbazepine acetate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Eslicarbazepine acetate

\Organic compound\Organic nitrogen compound\Eslicarbazepine acetate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2987348013 Eslicarbazepine acetate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2987374019 Eslicarbazepine acetate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Eslicarbazepine acetate	Is a	Eslicarbazepine	false	Inferred relationship	Some
Eslicarbazepine acetate	Has disposition (attribute)	Cytochrome P450 2C19 inhibitor	true	Inferred relationship	Some
Eslicarbazepine acetate	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Eslicarbazepine acetate	Is a	Anticonvulsant (substance)	true	Inferred relationship	Some
Eslicarbazepine acetate	Is a	Cytochrome P450 2C19 inhibitor	true	Inferred relationship	Some
Eslicarbazepine acetate	Is modification of (attribute)	Eslicarbazepine	true	Inferred relationship	Some
Eslicarbazepine acetate	Is a	Organic nitrogen compound	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely eslicarbazepine acetate 200 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Product containing precisely eslicarbazepine acetate 200 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Product containing precisely eslicarbazepine acetate 800 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Product containing precisely eslicarbazepine acetate 800 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Eslicarbazepine acetate 50 mg/mL oral suspension	Has precise active ingredient	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Eslicarbazepine acetate 50 mg/mL oral suspension	Has basis of strength substance (attribute)	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Product containing precisely eslicarbazepine acetate 400 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Product containing precisely eslicarbazepine acetate 400 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Eslicarbazepine acetate 600 mg oral tablet	Has precise active ingredient	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Eslicarbazepine acetate 600 mg oral tablet	Has basis of strength substance (attribute)	True	Eslicarbazepine acetate	Inferred relationship	Some	1

This concept is not in any reference sets